The Cepheid FleXible Cartridge program plans to accelerate menu expansion in Europe and China through partnerships with selected Trusted Reagent Manufacturers (TRMs). Through this program, GeneXpert^® System users will gain access to new CE-IVD and China NMPA approved tests in addition to Cepheid’s expanding line of Xpress and Multiplexed Xpert assays.

The first FleXible Cartridge test to be launched as part of this program will be the SpeeDx ResistancePlus^® MG test for the simultaneous detection of M. genitallium and associated drug resistance.

"Our new FleXible Cartridge program allows TRMs to develop targeted molecular tests using Cepheid’s easy-to use-cartridge," said David H. Persing, M.D., Ph.D., Cepheid's Chief Medical and Technology Officer. "With a global installed base of nearly 22,000 GeneXpert Systems, this technology could potentially be applied in multiple settings in which actionable treatment information is needed quickly."